-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SDHt3OdPXs0qOfI49pYXq3pq7HjGkMLxQzOH+JQE/cw1mIJUL+NuP4fvr/C4mCRq w7LkOmtOjwtNc6np69FqWw== 0001209191-09-039341.txt : 20090806 0001209191-09-039341.hdr.sgml : 20090806 20090806143151 ACCESSION NUMBER: 0001209191-09-039341 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090731 FILED AS OF DATE: 20090806 DATE AS OF CHANGE: 20090806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carlander Carrie E CENTRAL INDEX KEY: 0001469779 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30489 FILM NUMBER: 09991179 MAIL ADDRESS: STREET 1: 11545 W. BERNARDO COURT STREET 2: SUITE 301 CITY: SAN DIEGO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841097796 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11545 WEST BERNARDO COURT STREET 2: SUITE 301 CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 858-312-8000 MAIL ADDRESS: STREET 1: 11545 WEST BERNARDO COURT STREET 2: SUITE 301 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 3 1 doc3.xml FORM 3 SUBMISSION X0203 3 2009-07-31 0 0000849146 Lifevantage Corp LFVN 0001469779 Carlander Carrie E 11545 W. BERNARDO COURT SUITE 301 SAN DIEGO CA 92127 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 0.54 2010-07-31 2019-07-31 Common Stock 500000 D Option to purchase 500,000 shares vests and becomes exercisable on July 31, 2010 at an exercise price of $0.54 per share. /s/ Carrie E. Carlander 2009-08-06 -----END PRIVACY-ENHANCED MESSAGE-----